To consider and approve the Unaudited Financial results along with the Limited Review Report for the quarter and half year ended 30th September, 2026 and Request received for withdrawal of application for reclassification of shareholder from "Promoter and Promoter Group" to "Public Category".

Date: 30th October, 2026 To, To, The Manager (Listing) Listing Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No. C/1, G Block, Dalal Street, Fort, Mumbai - 400 001 Bandra-Kurla Complex, BSE Symbol: ANUHPHR Bandra (East), Mumbai – 400051 BSE Scrip Code: 506260 NSE Symbol: ANUHPHR; Series: EQ Subject: Outcome of Board Meeting dated, 30th October, 2026. Dear Sir/Madam, Pursuant to Regulation 30 and 33 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we wish to inform you that the Board of Directors of Anuh Pharma Limited (the Company) at its meeting held today, Friday, 30th October, 2026, has inter alia considered and approved the following: 1. The Un-Audited Financial Results along with Limited Review Report for the quarter and half year ended 30th September, 2026 (annexed as Annexure – A); 2. The requests received from the following Shareholder forming part of Promoter Group of the Company seeking withdrawn her application for reclassification and shall continue to remain a part of Promoter Group of the Company. Number of Sr % of Name Equity shares No. shareholding held 1. Nina Vijay Shah 60,000 0.06 TOTAL 60,000 0.06 The Withdrawal request has been annexed as Annexure – B; The Meeting of the Board of Directors commenced at 01:00 p.m. and concluded at 04:10 p.m. Kindly take the above on your records. Thanking you, Yours faithfully, FOR ANUH PHARMA LIMITED MANAN VADHAN COMPANY SECRETARY & COMPLIANCE OFFICER Encl: a/a Annexure - A ANUH PHARMA LTD. CIN: L24230MH1960PLC011586 Regd. Office: 3-A, North Wing, Shivsagar Estate, Dr. Annie Besant Road, Worli, Mumbai -400018 Tel: +91 22 6622 7575; Fax: +91 22 6622 7600; Email: anuh@sk1932.com;Website:www.anuhpharma.com UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED 30th SEPTEMBER, 2026 (Rs. in Lakhs) 3 months 3 months 3 months 6 months 6 months 12 months ended ended ended ended ended ended Sr. 30/09/2026 30/06/2026 30/09/2025 30/09/2026 30/09/2025 31/03/2026 Particulars Unaudited Unaudited Unaudited Unaudited Unaudited Audited (1) (2) (3) (4) (5) (6) (7) (8) I Revenue from operations 18,524.14 19,381.04 18,588.27 37,905.18 37,236.21 77, 165.74 II Other income 60.84 307.67 97.85 368.51 436.69 435.56 Ill Total Revenue (I+ II) 18,584.98 19,688.71 18,686.12 38,273.69 37,672.90 77,601.30 IV Expenses: Cost of materials consumed 14, 182.71 15,996.42 13,151.03 30,179.13 25,541.53 51,044.32 Purchases of Stock-in-Trade 48.02 414.33 1,839.16 462.35 4,488.80 7,919.67 Changes in inventories of finished goods, (453.59) (1,579.88) (536.84) (2,033.47) (314.58) 1,002.09 work-in-progress and Stock-in-Trade Employee benefits expense 745.78 735.16 674.55 1,480.94 1,304.34 2,630.33 Finance costs 5.18 0.35 7.56 5.53 28.69 47.23 Depreciation and amortization expense 245.18 243.28 286.18 488.46 537.68 1,138.22 Other expenses 2,306.93 2, 186.24 2,272.42 4,493.17 3,999.07 8,397.30 Total expenses (IV) 17,080.21 17,995.90 17,694.06 35,076.11 35,585.53 72,179.16 v Profit I (Loss) before exceptional and 1,504.77 1,692.81 992.06 3,197.58 2,087.37 5,422.14 items and tax (Ill -IV) VI Exceptional items - - - - - - VII Profit I (Loss) before tax (V -VI) 1,504.77 1,692.81 992.06 3,197.58 2,087.37 5,422.14 VIII Tax expenses: (1) Current tax 393.40 413.20 280.00 806.60 529.00 1,518.10 (2) Deferred tax (9.94) 137.12 . (49.19) 127.18 (33.00) (184.39) (3) Income tax of earlier years - - - - (16.18) Total Tax expenses (VIII) 383.46 550.32 230.81 933.78 496.00 1,317.53 IX Profit/(Loss) after Tax (VII-VIII) 1,121.31 1, 142.49 761.25 2,263.80 1,591.37 4,104.61 x Other Comprehensive Income (i) Items that will not be reclassified to 17.38 (4.40) 11.19 12.98 3.08 24.73 profit or loss (ii) Income Tax relating to the items that (4.38) 1.11 (2.82) (3.27) (0.78) (6.22) will not be reclassified to profit or loss (ii) Items that will be reclassified to profit or - - - - - loss Total Other Comprehensive Income 13.00 (3.29) 8.37 9.71 2.30 18.51 (net of Tax) (Xl (net of Tax) Total Comprehensive Income for the period (IX + X) (Comprising Profit I XI 1,134.31 1,139.20 769.62 2,273.51 1,593.67 4,123.12 (Loss) and Other Comprehensive Income for the period) Paid up Equity Stiare Capital (Face value Rs. 5/-each) (Refer 5,011.20 5,011.20 5,011.20 5,011.20 5,011.20 5,011.20 note no. 4) Other Equity - - - 30,211.04 (excluding revaluation reserves) Earnings per equity share XII (For respective periods) (In Rs.) (Refer note no. 4) (1) Basic 1.12 1.14 0.76 2.26 1.59 4.10 (2) Diluted 1.12 1.14 0.76 2.26 1.59 4.10 See accompanying notes to the financial results STATEMENT OF ASSETS AND LIABILITIES (Rs in Lakhs) As at 30th As at 31st September, PARTICULARS March, 2026 2026 Unaudited Audited I ASSETS 1 Non-current Assets (a) Property,P lant and equipment 4,472.49 4,799.41 (b) Capital work-in-progress 24.97 (c) Intangible Assets 43.57 52.89 (d) Right of use assets 797.28 809.77 5,338.31 5,662.07 (e) Financial Assets (i) Investments 2,506.52 3,960.07 (ii) Loans and Advances 9.00 (ii) Other Financial Assets 598.53 583.92 (f) Deferred Tax Assets (Net) 255.76 386.20 ( g) Other Non Current Assets 28.19 5.78 Total Non-Current Assets 8,727.31 10,607.04 2 Current Assets (a) Inventories 17,245.36 14,775.50 (b) Financial Assets (i) Investments 8,778.46 4,484.16 (ii) Trade receivables 18,978.01 23,863.28 (iii) Cash and cash equivalents 939.93 805.97 (iv) Other Bank balances 44.89 24.18 (v) Loans and Advances 106.09 82.64 (vi) Other financial assets 53.50 94.11 (c) Other current assets 492.49 999.91 Total Current Assets 46,638.73 45,129.75 TOTAL ASSETS 55,366.04 55 736.79 II EQUITY AND LIABILITIES EQUITY (i) Equity Share Capital 5,011.20 5,011.20 (ii) Other Equity 30,981.18 30,211.04 TOTAL EQUITY 35,992.38 35,222.24 Liabilities 1 NON-CURRENT LIABLITIES (a) Financial Liaiblities (i) Lease Liabilities (b) Provisions 184.57 214.22 TOTAL NON-CURRENT LIABLITIES 184.57 214.22 2 CURRENT LIABLITIES (a) Financial Liaiblities (i) Borrowings 1,947.58 (ii) Lease Liabilities 5.83 (iii) Trade Payables: Due to Micro and Small Enterprises 445.51 233.51 Due to other than Micro and Small Enterprises 14,211.44 18,532.21 (iv) Other financial liabilities 1,195.14 767.39 (b) Other current liabilities 1,235.09 503.27 (c) Provisions 31.37 26.50 (d) Current Tax Liabilities(Net) 122.96 231.62 TOTAL CURRENT LIABLITIES ·19,189.09 20,300.33 TOTAL EQUITY AND LIABILITIES 55 366.04 55 736.79 ANUH PHARMA LIMITED CASH FLOW STATEMENT FOR THE HALF YEAR ENDED 30th September. 2026 (Rs. in Lakhs) Half Year Ended 30th Half Year Ended 30th Particulars September 2026 September 2025 Unaudited Unaudited (A) CASH FLOW FROM OPERATING ACTIVITIES: NET PROFIT BEFORE TAX 3,197.58 2,087.37 Adjustment for: Depreciation and Amortization 488.46 . 537.68 Finance Costs 5.53 28.69 Interest Income (25.45) (34.63) Property, Plant and Equipment W/Off I Discarded 0.82 - Foreign Exchange (Gain)/Loss (Unrealised) (256.77) 77.91 Market to Market (gain)/ loss on investment (Net) (135.75) 54.39 Market to Market loss I (gain) on Derivative (Net) (11.42) (0.86) Sundry Credit Balance Written Back (13.59) (36.81) Bad Debts Written Off 9.03 - Fair Valuation on Unquoted Equity Share 88.35 - Dividend Income (3.17) (2.82) (Profit)/Loss on Sale of Property.Plant and Equipment (Net) - (8.38) (Profit)/Loss on Sale of Investment (Net) (202.95) (390.86) (56.91) 224.31 OPERATING PROFIT BEFORE WORKING CAPITAL CHANGES 3,140.67 2,311.68 Adjustment for: Trade and Other Receivables 4,717.81 (1,659.80) Inventories (2,469.86) (4,372.95) Other Financial Assets (35.33) 990.57 Loans and Advances (14.46) (5.15) Other Current Assets 505.54 193.41 Trade Payables (3,613.08) 409.28 Other Financial Liabilities 402.86 464.33 Other current Liabilities 731.82 (236.96) 225.30 (4,217.27) CASH GENERATED FROM OPERATIONS 3,365.97 (1,905.59) Direct Taxes paid (Net) (697.74) (697.74) (774.37) (774.37) NE [Showing first 8,000 characters — download PDF for full document]